InCarda’s CEO Grace Colon participated in a panel discussion at Biotech Showcase 2021 on January 11, 2021
Our CEO Grace Colón participated in the panel “Cardiovascular and Nephrology: a Renewed Interest” at Biotech Showcase 2021 on January 11, 2021. More information below:
Drug development in nephrology and cardiovascular specialties have had a revival of venture investments in recent years, after facing headwinds regarding capital-intensive trials and a challenging reimbursement landscape. During the panel discussion, we will touch upon topics including the tailwinds in the space from the perspectives of investment, advancements in the scientific body of knowledge, clinical development and regulatory approaches.